Global point of care
Risk of co-infection with SARS-CoV-2 and the dengue virus (DENV)
The diagnostic challenge is that COVID-19 and dengue share similar symptoms and laboratory features. Working with us, we can provide a reliable and trusted solution to empower you for faster triaging, management and treatment of both diseases.
Make faster, better decisions in the moment with point-of-care testing
Contact us for More information



Bioline™ DENGUE DUO
(DENGUE NS1 Ag + IgG/IgM)
- Rapid immunochromatographic assay designed to detect both dengue virus NS1 antigen and antibodies IgG/IgM against dengue virus in human whole blood, serum or plasma
- Cover all clinical stages from acute phase to converlescence
- Fast test result: 15-20 minutes



PANBIO™ COVID-19 Ag
Rapid test device (Nasal)
- High performance compared to nasal PCR Nasal swab vs Nasopharyngeal PCR:
Sensitivity 98.1%/Specificity 99.8% - Patients with Ct >33 are no longer contagious
- Fast test result: 15-20 minutes
Risk of co-infection with SARS-CoV-2 and the dengue virus (DENV)
The diagnostic challenge is that COVID-19 and dengue share similar symptoms and laboratory features. Working with us, we can provide a reliable and trusted solution to empower you for faster triaging, management and treatment of both diseases.
Make faster, better decisions in the moment with point-of-care testing



Bioline™ DENGUE DUO
(DENGUE NS1 Ag + IgG/IgM)
- Rapid immunochromatographic assay designed to detect both dengue virus NS1 antigen and antibodies IgG/IgM against dengue virus in human whole blood, serum or plasma
- Cover all clinical stages from acute phase to converlescence
- Fast test result: 15-20 minutes



PANBIO™ COVID-19 Ag
Rapid test device (Nasal)
- High performance compared to nasal PCR Nasal swab vs Nasopharyngeal PCR:
Sensitivity 98.1%/Specificity 99.8% - Patients with Ct >33 are no longer contagious
- Fast test result: 15-20 minutes